EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS

December 8, 2020 updated by: Mary De Vera, University of British Columbia
Between 8% and 12% of Canadians suffer from asthma. Although there are effective and inexpensive treatments, adherence to asthma treatment is amongst the lowest for all chronic diseases.The purpose of this study is to determine whether enhancing the role of community pharmacists in asthma management using interactive short messaging service (SMS) with asthma patients is a cost-effective model that will improve adherence to inhaled corticosteroid medications compared to usual care.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

271

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • British Columbia
      • Vancouver, British Columbia, Canada, V6T 1Z3
        • UBC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • individuals who fill a (incident or prevalent) prescription for inhaled corticosteroids (either monotherapy or in combination inhaler with long-acting beta-agonists) who have been diagnosed by a doctor as having asthma
  • possessing a cell-phone with ability to send/receive text messages
  • residing in British Columbia (BC), Canada and planning to reside in BC for the next 12 months
  • registered with the medical services plan (MSP, the provincial insure of medically-required services) in the past 12 months, and planning to remain registered for the next 12 months
  • designated pharmacy being the main drugstore for patient
  • not participating in another interventional study
  • consent to participate in the study.

Exclusion Criteria:

  • Unable to communicate in English
  • Under 14 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interactive SMS
Intervention with interactive SMS (text messaging) by which patients are asked to disclose their level of agreement with the following statement "I follow my asthma medication plan" and pharmacist follow-up
Other: Interactive SMS
Active Comparator: Usual care
Pharmacist conducted patient education, counseling and action-plan
Other: Usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to inhaled corticosteroid medication
Time Frame: 12 months
Adherence assessed by medication possession ratio
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Asthma control
Time Frame: Baseline
Asthma control assessed by the Asthma Control Test
Baseline
Asthma control
Time Frame: 6 months
Asthma control assessed by the Asthma Control Test
6 months
Asthma control
Time Frame: 12 months
Asthma control assessed by the Asthma Control Test
12 months
Quality of life measured by the Asthma Quality of Life Questionnaire
Time Frame: Baseline
Quality of life measured by the Asthma Quality of Life Questionnaire
Baseline
Quality of life measured by the Asthma Quality of Life Questionnaire
Time Frame: 3 months
Quality of life measured by the Asthma Quality of Life Questionnaire
3 months
Quality of life measured by the Asthma Quality of Life Questionnaire
Time Frame: 12 months
Quality of life measured by the Asthma Quality of Life Questionnaire
12 months
Health care resource utilization
Time Frame: 12 months
Asthma-related hospital admissions and emergency department visits
12 months
Use of reliever medication for acute asthma attacks
Time Frame: 12 months
Use of reliever medication for acute asthma attacks
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of British Columbia

Collaborators

Canadian Institutes of Health Research (CIHR)
WelTel
College of Pharmacists of British Columbia

Investigators

  • Principal Investigator: Mary De Vera, PhD, University of British Columbia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (Actual)

March 1, 2019

Study Completion (Actual)

March 1, 2019

Study Registration Dates

First Submitted

June 19, 2014

First Submitted That Met QC Criteria

June 19, 2014

First Posted (Estimate)

June 23, 2014

Study Record Updates

Last Update Posted (Actual)

December 10, 2020

Last Update Submitted That Met QC Criteria

December 8, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • H14-01451

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma

Clinical Trials on Usual care

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe